These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 32988887)

  • 1. High Expression of p21 as a Potential Therapeutic Target in Ovarian Clear-cell Carcinoma.
    Minagawa Y; Ishino K; Wada R; Kudo M; Naito Z; Takeshita T; Ohashi R
    Anticancer Res; 2020 Oct; 40(10):5631-5639. PubMed ID: 32988887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MBNL2 Regulates DNA Damage Response via Stabilizing p21.
    Cai J; Wang N; Lin G; Zhang H; Xie W; Zhang Y; Xu N
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models.
    Colin DJ; Limagne E; Ragot K; Lizard G; Ghiringhelli F; Solary É; Chauffert B; Latruffe N; Delmas D
    Cell Death Dis; 2014 Nov; 5(11):e1533. PubMed ID: 25412311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
    Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
    Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
    Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.
    Carrassa L; Broggini M; Erba E; Damia G
    Cell Cycle; 2004 Sep; 3(9):1177-81. PubMed ID: 15326376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
    Liu T; Qin W; Hou L; Huang Y
    Tumour Biol; 2015 Mar; 36(3):1881-93. PubMed ID: 25510663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.
    Plisiecka-Hałasa J; Karpińska G; Szymańska T; Ziółkowska I; Madry R; Timorek A; Debniak J; Ułańska M; Jedryka M; Chudecka-Głaz A; Klimek M; Rembiszewska A; Kraszewska E; Dybowski B; Markowska J; Emerich J; Płuzańska A; Goluda M; Rzepka-Górska I; Urbański K; Zieliński J; Stelmachów J; Chrabowska M; Kupryjańczyk J
    Ann Oncol; 2003 Jul; 14(7):1078-85. PubMed ID: 12853350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity.
    Cai KQ; Wu H; Klein-Szanto AJ; Xu XX
    Gynecol Oncol; 2009 Jul; 114(1):18-25. PubMed ID: 19375154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas.
    Saegusa M; Machida B D; Okayasu I
    Cancer; 2001 Sep; 92(5):1177-89. PubMed ID: 11571731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S; Olivero M; Corà D; Di Renzo MF
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
    Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
    J Virol; 2019 May; 93(9):. PubMed ID: 30787154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
    Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
    Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
    Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
    Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress.
    Rodriguez R; Meuth M
    Mol Biol Cell; 2006 Jan; 17(1):402-12. PubMed ID: 16280359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemanthamine alters sodium butyrate-induced histone acetylation, p21
    Seifrtová M; Havelek R; Cahlíková L; Hulcová D; Mazánková N; Řezáčová M
    Phytomedicine; 2017 Nov; 35():1-10. PubMed ID: 28991639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaempferol Induces G2/M Cell Cycle Arrest via Checkpoint Kinase 2 and Promotes Apoptosis via Death Receptors in Human Ovarian Carcinoma A2780/CP70 Cells.
    Gao Y; Yin J; Rankin GO; Chen YC
    Molecules; 2018 May; 23(5):. PubMed ID: 29734760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
    Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
    Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.